Navigation Links
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
Date:8/1/2013

approval of BELVIQ in Canada.

BELVIQ Additional Developments 

  • BELVIQ has been nominated for the 2013 Prix Galien USA Best Pharmaceutical Agent Award. The Prix Galien recognizes outstanding achievements in improving the human condition through the development of innovative therapies.
  • Presented a poster, Lorcaserin HCl Phase 3 Trials in Obese and Overweight Patients: Week 52 Outcomes for Those Achieving at Least 5% Weight Loss at Week 12, at the American Diabetes Association's 73rd Scientific Sessions in Chicago, Illinois.
  • The American Medical Association recognized obesity as a disease state with multiple pathophysiological aspects requiring a range of interventions to advance obesity treatment and prevention.
  • Presented a poster, Association of Changes in Glycemic- and Lipid-Related Cardiometabolic Risk Factors and Weight Loss in Pooled Lorcaserin Phase 3 Studies of Obese and Overweight Patients Without Diabetes (BLOOM and BLOSSOM), at ENDO 2013, the Endocrine Society's 95th Annual Meeting & Expo in San Francisco, California.
  • Research & Development 

  • Completed dosing in a study to evaluate the safety, tolerability and pharmacokinetic properties of BELVIQ and phentermine when administered in combination. In addition, agreed on plans with Eisai to initiate a 12-week pilot study to evaluate the co-administration of BELVIQ and phentermine.
  • Completed dosing in a Phase 1 multiple-dose clinical trial of APD811, an oral drug candidate intended for the treatment of pulmonary arterial hypertension. Arena expects to announce results from the Phase 1 program this quarter.  
  • Completed dosing in a Phase 1 clinical trial of APD334, an oral drug candidate intended for the treatment of autoimmune diseases. Preliminary results show a reduction in blood lymphocyte count, the desired benefit, and a slowing of heart rate, an undesirable adverse event seen with
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, August 1
    2. Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
    3. Former Semi-Pro Arena Football Player Bridged to Heart Transplant with the SynCardia Total Artificial Heart
    4. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
    5. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
    6. Carena Launches 24/7 Virtual Care Delivery Service for Hospital Systems and Primary Care Clinics
    7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
    8. Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Thursday, May 2
    9. Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
    10. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
    11. Arena Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... ANGELES , Jan. 23, 2015 A lot of ... best methods for treating  certain illnesses, injuries, or conditions. As ... replace previous treatment methods with ones that they consider to ... hernias, there is not one textbook method of treatment that ...
    (Date:1/23/2015)... WYNNEWOOD, Pa. , Jan. 23, 2015  MedScope ( ... has been nominated for a 2015 Connected World ... Personal Emergency Response System (mPERS), that can be used ... M2M technology partner.  In nominating MedScope, ...
    (Date:1/23/2015)...  HyGreen, Inc., a leader in hand hygiene monitoring, today ... a subsidiary of Ascendis Health Limited, in ... hundreds of millions of patients around the world are ... from patient to patient via the unwashed hands of ...
    Breaking Medicine Technology:No One-Size-Fits-All Remedy for Hernia Correction 2MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
    (Date:1/22/2015)... 22, 2015 For over 20 years, Dr. David ... and Vista area has treated just about every type of ... circumstances. And for those same twenty-plus years, the team at ... those injuries with the best possible doctor. With the ...
    (Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... American College of Sports Medicine flagship journal Medicine ... supplementation with L-Citrulline before exercise may help reduce ... strenuous exercise. 1 , Participants in the ...
    (Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
    (Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
    (Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list of ... . , Some types of vehicles cannot be covered under ... blog post to see if their vehicle qualifies for auto insurance ... of the cars that cannot be covered by a plan. Clients ...
    Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
    ... Kurtz Resigns as President and Chief Executive Officer; Evelyn ... Appointed Acting Chief Executive Officer -, LA JOLLA, Calif., ... announced that Neil Kurtz, M.D., is,resigning as President, Chief Executive ... 31, 2008. Dr. Kurtz is leaving TorreyPines,to assume the role ...
    ... a San Diego biotech company, developed the first method to ... iron and its distribution in the body. This ... millions of people worldwide such as anemias and iron overload ... the amount of hepcidin in the blood. When levels ...
    ... Patients and Helps ... Money for Make-A-Wish Foundation, PITTSBURGH, Aug. 8 Aethon ... robot to children,s,hospitals across the country. Also, Aethon will make ... that is deployed. The JR,TUG was initially introduced at the ...
    ... surgery, pair of studies finds , , FRIDAY, Aug. 8 (HealthDay ... not be accurate for obese men, leaving them more vulnerable ... effective for them, a new pair of studies found. , ... aggressive form of the disease," said Dr. Stephen Freedland, an ...
    ... Cervical Cancer Screening Participants Receive $15 ... ... Aug. 8 Keystone Mercy Health Plan, the,largest medical assistance ... Inc. (DVCH), a,non-profit organization that provides community-based, primary medical,dental and ...
    ... the Harvard School of Public Health, today expressed "deep ... Kamiar Alaei, a 2007 Masters of Science graduate of ... The brothers are Iranian physicians working on the prevention ... in their country." , , "There is concern for their ...
    Cached Medicine News:Health News:TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results 2Health News:TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results 3Health News:TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results 4Health News:TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results 5Health News:TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results 6Health News:TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results 7Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 2Health News:Charlotte Children's Hospital Gets a Delivery from Aethon's Train-Themed Robot This Fall 3Health News:Obese Men Face Twin Threat From Prostate Cancer 2Health News:Keystone Mercy and DVCH to Offer Screenings for National Health Center Week 2
    CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, exclu...
    ... the surgical versatility you demand when treating ... EBI OsteoGen-D offers 40 microamperes of direct ... with 20 microamperes. Available in both Mesh ... flexibility with any of your bone graft ...
    ... area contact between grant material and fracture ... long bones., ,Grid-Like Format of Mesh Cathode ... Bone , ,The innovative Mesh Cathode of ... area and a scaffolding effect designed to ...
    Flowmate makes portable uroflowmetry easy, accurate and dignified. Flowmate has automatic start and stop as well as simple and straightforward reporting from its own printer....
    Medicine Products: